000046928 000__ 01069cam\a22003975i\4500
000046928 001__ 46928
000046928 003__ SzGeWIPO
000046928 005__ 20230504104737.0
000046928 006__ m\\\\eo\\d\\\\\\\\
000046928 007__ cr bn |||m|||a
000046928 008__ 221017s2022\\\\nyu\\\\\o\\\\\000\0\eng\d
000046928 035__ $$a(OCoLC)1348116843
000046928 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000046928 041__ $$aeng
000046928 24500 $$aIn defence of the importance of human rights for the improvement of access to patented medicines: a response to Thambisetty.
000046928 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2022
000046928 300__ $$a1 online resource
000046928 336__ $$atext$$2rdacontent
000046928 337__ $$acomputer$$2rdamedia
000046928 338__ $$aonline resource$$bcr$$2rdacarrier
000046928 4901_ $$aIntellectual Property Quarterly,$$vVolume 2;
000046928 542__ $$fhttps://1.next.westlaw.com/Copyright
000046928 588__ $$aCrossref
000046928 590__ $$aPublished online: 2022
000046928 650_0 $$aIntellectual property.
000046928 650_4 $$aDeveloping countries
000046928 650_4 $$aPharmaceuticals
000046928 650_0 $$aPatents.
000046928 7001_ $$aPeck, Thomas J.W.,$$eauthor.
000046928 7731_ $$tIntellectual Property Quarterly
000046928 7731_ $$wIPQUA
000046928 830_0 $$aIntellectual Property Quarterly;$$vI.P.Q. 2022, 2, 51-61
000046928 85641 $$uhttps://www.westlaw.com/Document/IA5B16AD0ED0511EC91B2DFBECD397515/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000046928 904__ $$aArticle
000046928 980__ $$aIPQUA